ABELCET: Package Insert and Label Information (Page 3 of 3)

HOW SUPPLIED

Single-use vials along with 5-micron filter needles are individually packaged.

100 mg of ABELCET ® in 20 mL of suspension NDC 57665-101-41

Storage

Prior to admixture, ABELCET ® should be stored at 2° to 8°C (36° to 46°F) and protected from exposure to light. Do not freeze. ABELCET ® should be retained in the carton until time of use.

The admixed ABELCET ® and 5% Dextrose Injection may be stored for up to 48 hours at 2° to 8°C (36° to 46°F) and an additional 6 hours at room temperature. Do not freeze. Any unused material should be discarded.

U.S. Patent Nos. 4,973,465

5,616,334

6,406,713

I-101-41-US-Q

Leadiant Logo

Manufactured by Exelead, Inc., Indianapolis, IN 46268

Distributed by Leadiant Biosciences, Inc., Gaithersburg, MD 20878

Revised 11/2018

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

NDC 57665-101-41

100 mg

ABELCET®
(Amphotericin B Lipid Complex Injection)

Lipid
Formulation

For Intravenous Use Only

5 mg/mL

Contents:
One 100 mg vial
One filter needle

Manufactured by:
Exelead, Inc.
Indianapolis, IN 46268

Distributed by: Leadiant
Biosciences, Inc.
Gaithersburg, MD 20878

U.S. PATENT NOS. 4,973,465 5,616,334 6,406,713

C-101-41-US-M

NDC 57665-101-41

100 mg

ABELCET®
(Amphotericin B Lipid Complex Injection)

For Intravenous Use Only

Each mL of ABELCET contains:
Amphotericin B USP 5 mg
L-α-dimyristoylphosphatidylcholine (DMPC) 3.4 mg
L-α-dimyristoylphosphatidylglycerol (DMPG) 1.5 mg
Sodium Chloride USP 9 mg
Water for Injection USP, q.s. 1 mL

Preparation
ABELCET must be added to 5% Dextrose Injection USP
before intravenous infusion.
See package insert for complete directions.

Dosage
See package insert for dosage and administration information.

Storage
Store between 2° and 8°C (36° to 46°F). Do not freeze. Protect from light. Single-use vial.

Rx Only.

Principal Display Panel -- Carton Label
(click image for full-size original)
ABELCET amphotericin b, dimyristoylphosphatidylcholine, dl- and dimyristoylphosphatidylglycerol, dl- injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:57665-101
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
AMPHOTERICIN B (AMPHOTERICIN B) AMPHOTERICIN B 5 mg in 1 mL
DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL- (DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-) DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL- 3.4 mg in 1 mL
DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL- (DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-) DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL- 1.5 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:57665-101-41 1 VIAL in 1 CARTON contains a VIAL
1 20 mL in 1 VIAL This package is contained within the CARTON (57665-101-41)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA050724 10/18/2010
Labeler — Leadiant Biosciences, Inc. (068301431)

Revised: 12/2022 Leadiant Biosciences, Inc.

Page 3 of 3 1 2 3

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.